1. Nowell PC. The clonal evolution of tumor cell populations // Science. 1976. Vol. 194, N 4260. P. 23–28.
2. Merlo L.M., Pepper J.W., Reid B.J. et al. Cancer as an evolutionary and ecological process // Nat. Rev. Cancer. 2006. Vol. 6, N 12. P. 924–935.
3. Greaves M., Maley C.C. Clonal evolution in cancer // Nature. 2012. Vol. 481, N 7381. P. 306–313.
4. Landgren O., Albitar M., Ma W. et al. B-cell clones as early markers for chronic lymphocytic leukemia // N. Engl. J. Med. 2009. Vol. 360, N 7. P. 659–667.
5. Dohner H., Stilgenbauer S., Benner A. et al. Genomic aberrations and survival in chronic lymphocytic leukemia // N. Engl. J. Med. 2000. Vol. 343, N 26. P. 1910–1916.
6. Damle R.N., Wasil T., Fais F. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia // Blood. 1999. Vol. 94, N 6. P. 1840–1847.
7. Hamblin T.J., Davis Z., Gardiner A. et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia // Blood. 1999. Vol. 94, N 6. P. 1848–1854.
8. Puente X.S., Pinyol M., Quesada V. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia // Nature. 2011. Vol. 475, N 7354. P. 101–105.
9. Wang L., Lawrence M.S., Wan Y. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia // N. Engl. J. Med. 2011. Vol. 365, N 26. P. 2497–2506.
10. Quesada V., Conde L., Villamor N. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia // Nat. Genet. 2011. Vol. 44, N 1. P. 47–52.
11. Puente X.S., Beà S., Valdés-Mas R. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia // Nature. 2015. Vol. 526, N 7574. P. 519–524.
12. Kulis M., Heath S., Bibikova M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia // Nat. Genet. 2012. Vol. 44, N 11. P. 1236–1242.
13. Ferreira P.G., Jares P., Rico D. et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia // Genome Res. 2014. Vol. 24, N 2. P. 212–226.
14. Landau D.A., Tausch E., Taylor-Weiner A.N. et al. Mutations driving CLL and their evolution in progression and relapse // Nature. 2015. Vol. 526, N 7574. P. 525–530.
15. Juliusson G., Oscier D.G., Fitchett M. et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities // N. Engl. J. Med. 1990. Vol. 323, N 11. P. 720–724.
16. Moia R., Patriarca A., Deambrogi C. et al. An update on: molecular genetics of high-risk chronic lymphocytic leukemia // Expert Rev. Hematol. 2020. Vol. 13, N 2. P. 109–116.
17. Haferlach C., Dicker F., Schnittger S. et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping // Leukemia. 2007. Vol. 21, N 12. P. 2442–2451.
18. Rigolin G.M., Cibien F., Martinelli S. et al. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with «normal» FISH: correlations with clinicobiologic parameters // Blood. 2012. Vol. 119, N 10. P. 2310–2313.
19. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function // Cell. 2004. Vol. 116, N 2. P. 281–297.
20. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? // Nat. Rev. Genet. 2008. Vol. 9, N 2. P. 102–114.
21. Pekarsky Y., Croce C.M. Role of miR-15/16 in CLL // Cell Death Differ. 2015. Vol. 22, N 1. P. 6–11.
22. Quijano S., López A., Rasillo A. et al. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia // Cytometry B Clin. Cytom. 2008. Vol. 74, N 3. P. 139–149.
23. Klein U., Lia M., Crespo M. et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia // Cancer Cell. 2010. Vol. 17, N 1. P. 28–40.
24. Gruber M., Wu C.J. Evolving understanding of the CLL genome // Semin. Hematol. 2014. Vol. 51, N 3. P. 177–187.
25. Fabbri G., Rasi S., Rossi D. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation // J. Exp. Med. 2011. Vol. 208, N 7. P. 1389–1401.
26. Ramsay A.J., Quesada V., Foronda M. et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia // Nat. Genet. 2013. Vol. 45, N 5. P. 526–530.
27. Fabbri G., Khiabanian H., Holmes A.B. et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome // J. Exp. Med. 2013. Vol. 210, N 11. P. 2273–2288.
28. Landau D.A., Carter S.L., Stojanov P. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia // Cell. 2013. Vol. 152, N 4. P. 714–726.
29. Kanduri M., Cahill N., Göransson H. et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia // Blood. 2010. Vol. 115, N 2. P. 296–305.
30. Pei L., Choi J.H., Liu J. et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia // Epigenetics. 2012. Vol. 7, N 6. P. 567–578.
31. Cahill N., Bergh A.C., Kanduri M. et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments // Leukemia. 2013. Vol. 27, N 1. P. 150–158.